Lurbinectedin is a chemotherapy drug used to treat certain types of cancer, including small cell lung cancer. According to the sources provided, nausea and vomiting are common side effects of lurbinectedin. The Mayo Clinic [1] states that nausea and vomiting are among the most common side effects of the drug, and may occur within hours or days of treatment. MedlinePlus [2] also lists nausea and vomiting as potential side effects of lurbinectedin, along with other common side effects such as fatigue, hair loss, and decreased appetite. DrugPatentWatch [3] notes that nausea and vomiting are among the most frequently reported adverse events associated with lurbinectedin treatment.

In conclusion, based on the sources provided, it is clear that nausea and vomiting are common side effects of lurbinectedin treatment. Patients receiving this medication should be aware of these potential side effects and discuss any concerns with their healthcare provider.

Sources:
[1] https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1
[2] https://medlineplus.gov/druginfo/meds/a620049.html
[3] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN